DataArt to Demonstrate Technology Innovations for Drug Development and Clinical Trials at DPharm 2018, Boston, September 25-26

DataArt to Demonstrate Technology Innovations for Drug Development and Clinical Trials at DPharm 2018, Boston, September 25-26

New York, September 17, 2018 — DataArt, the global technology consultancy that designs, develops and supports unique software solutions, will participate in DPharm: Disruptive Innovations to Advance Clinical Trials in Boston, MA, September 25-26, 2018, to present its innovative concept apps for clinical trials. On show will be DataArt’s voice recognition and AI-enabled remote monitoring prototype, patient and investigator engagement solutions, and other innovative solutions.

At DataArt’s booth #22, Daniel Piekarz, SVP and Healthcare & Life Sciences Practice Leader, and Egor Kobelev, VP of Engineering, will be available to discuss how technology can innovate drug development and clinical trials.

The DataArt team will demonstrate:

Remote Monitoring prototype, created in partnership with Health Navigator, a platform offering a comprehensive clinical vocabulary and decision-support system designed to facilitate eHealth and telemedicine encounters. This R&D app has the potential to revolutionize the telehealth experience. It brings together real-time speech recognition (powered by IBM Watson) with natural language processing and clinical decision support systems to improve the patient-doctor experience, reduce costs, and dramatically save time for the EHR population.

A new Patient Engagement approach, demonstrated though KidPRO, the winner of the Pfizer Healthcare Challenge 2017 award and a runner-up for InnovateNYP: Pediatric App Challenge 2016. The prototype is a complete ePRO (electronic patient reported outcomes) system for pediatric clinical trials and consists of two interconnected applications: one for the child, one for the parents. The companion apps guide the patient and the caregiver through the daily schedule of a clinical trial, suggest personalized educational content and rewards for compliance.

The Investigator Site Engagement Platform, designed to improve patient engagement and protocol adherence in a clinical trial by ensuring the highest level of performance from investigator sites while giving sponsors real-time visibility. The prototype is a powerful tool that helps investigators by providing insights, predictive risk assessments and study KPI measurement.

DPharm: Disruptive Innovations to Advance Clinical Trials Event Details

Date:
September 25-26, 2018

Location:
Booth 22
Boston Marriott Copley Place, 110 Huntington Ave, Boston, MA 02116

About DataArt

DataArt is a global technology consultancy that designs, develops and supports unique software solutions, helping clients take their businesses forward. Recognized for their deep domain expertise and superior technical talent, DataArt teams create new products and modernize complex legacy systems that affect technology transformation in select industries.

DataArt has earned the trust of some of the world’s leading brands and most discerning clients, including Nasdaq, Travelport, Ocado, Betfair, Regus, Meetup and Apple Leisure Group among others. DataArt brings together expertise of over 2,500 professionals in 20 locations in the US, Europe, and Latin America.

www.dataart.com

@dataart

Welcome
We are glad you found us
Please explore our services and find out how we can support your business goals.